Key Financial Data Of Reporting Company

Daito Pharmaceutical Co., Ltd. - Filing #7545245

Concept As at
2023-05-31
As at
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
As at
2022-05-31
As at
2022-05-31
2020-06-01 to
2021-05-31
As at
2021-05-31
2020-06-01 to
2021-05-31
As at
2021-05-31
2019-06-01 to
2020-05-31
As at
2020-05-31
As at
2020-05-31
2019-06-01 to
2020-05-31
2018-06-01 to
2019-05-31
As at
2019-05-31
As at
2019-05-31
2018-06-01 to
2019-05-31
Key financial data of reporting company
Business results of reporting company
Net sales
45,101,000,000 JPY
44,695,000,000 JPY
43,464,000,000 JPY
43,197,000,000 JPY
48,714,000,000 JPY
48,474,000,000 JPY
44,991,000,000 JPY
44,799,000,000 JPY
41,134,000,000 JPY
40,924,000,000 JPY
Ordinary profit (loss)
5,169,000,000 JPY
5,082,000,000 JPY
6,729,000,000 JPY
6,240,000,000 JPY
6,067,000,000 JPY
5,342,000,000 JPY
5,462,000,000 JPY
4,733,000,000 JPY
4,641,000,000 JPY
4,132,000,000 JPY
Profit (loss)
3,491,000,000 JPY
4,412,000,000 JPY
3,686,000,000 JPY
3,474,000,000 JPY
3,145,000,000 JPY
Share capital
7,186,000,000 JPY
7,031,000,000 JPY
6,271,000,000 JPY
5,370,000,000 JPY
4,367,000,000 JPY
Total number of issued shares
14,416,000 xbrli:shares
14,293,000 xbrli:shares
13,719,000 xbrli:shares
13,173,000 xbrli:shares
12,519,000 xbrli:shares
Net assets
50,971,000,000 JPY
46,452,000,000 JPY
47,674,000,000 JPY
43,420,000,000 JPY
41,917,000,000 JPY
38,057,000,000 JPY
33,488,000,000 JPY
36,868,000,000 JPY
31,349,000,000 JPY
28,285,000,000 JPY
Total assets
70,552,000,000 JPY
65,404,000,000 JPY
64,939,000,000 JPY
59,719,000,000 JPY
57,739,000,000 JPY
53,065,000,000 JPY
50,093,000,000 JPY
54,249,000,000 JPY
46,749,000,000 JPY
42,669,000,000 JPY
Net assets per share
3,527.15
3,233.39
3,310.34
3,038.40
3,034.88
2,775.16
2,543.20
2,772.30
2,472.66
2,260.38
Dividend paid per share
60.00
60.00
46.00
46.00
38.00
Interim dividend paid per share
30.00
25.00
23.00
20.00
18.00
Basic earnings (loss) per share
250.39
242.81
335.41
317.01
311.02
270.02
309.66
272.74
280.73
251.37
Diluted earnings per share
250.17
242.59
307.44
270.79
Equity-to-asset ratio
0.718 xbrli:pure
0.710 xbrli:pure
0.728 xbrli:pure
0.727 xbrli:pure
0.721 xbrli:pure
0.717 xbrli:pure
0.668 xbrli:pure
0.673 xbrli:pure
0.662 xbrli:pure
0.663 xbrli:pure
Rate of return on equity
0.073 xbrli:pure
0.078 xbrli:pure
0.105 xbrli:pure
0.108 xbrli:pure
0.109 xbrli:pure
0.103 xbrli:pure
0.117 xbrli:pure
0.112 xbrli:pure
0.114 xbrli:pure
0.111 xbrli:pure
Price-earnings ratio
9.20 xbrli:pure
9.48 xbrli:pure
7.80 xbrli:pure
8.26 xbrli:pure
10.55 xbrli:pure
12.15 xbrli:pure
14.08 xbrli:pure
15.99 xbrli:pure
11.99 xbrli:pure
13.39 xbrli:pure
Payout ratio
0.247 xbrli:pure
0.189 xbrli:pure
0.170 xbrli:pure
0.169 xbrli:pure
0.151 xbrli:pure
Net cash provided by (used in) operating activities
4,155,000,000 JPY
4,370,000,000 JPY
5,182,000,000 JPY
4,306,000,000 JPY
6,888,000,000 JPY
Net cash provided by (used in) investing activities
-5,566,000,000 JPY
-4,400,000,000 JPY
-6,324,000,000 JPY
-2,681,000,000 JPY
-3,867,000,000 JPY
Net cash provided by (used in) financing activities
616,000,000 JPY
989,000,000 JPY
1,424,000,000 JPY
-350,000,000 JPY
-2,898,000,000 JPY
Cash and cash equivalents
3,607,000,000 JPY
4,381,000,000 JPY
3,372,000,000 JPY
3,084,000,000 JPY
1,819,000,000 JPY
Number of employees
1,011 xbrli:pure
821 xbrli:pure
915 xbrli:pure
743 xbrli:pure
846 xbrli:pure
676 xbrli:pure
624 xbrli:pure
784 xbrli:pure
735 xbrli:pure
589 xbrli:pure
Average number of temporary employees
49 xbrli:pure
48 xbrli:pure
57 xbrli:pure
56 xbrli:pure
54 xbrli:pure
53 xbrli:pure
44 xbrli:pure
45 xbrli:pure
36 xbrli:pure
35 xbrli:pure
Total shareholder return
0.706 xbrli:pure
0.776 xbrli:pure
0.943 xbrli:pure
1.229 xbrli:pure
0.941 xbrli:pure
Total return on share price index
1.378 xbrli:pure
1.203 xbrli:pure
1.182 xbrli:pure
0.941 xbrli:pure
0.886 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.